For laboratory research use only · Not for human or veterinary use · 18+
Growth hormone research

Buy IGF-1 LR3 Peptide in Australia

Lyophilised powder, 0.1mg vial · Available to order, dispatched from Australia
Choose strength: 0.1 MG
$48.99

Buy IGF-1 LR3 in Australia from Macropus Peptides in 0.1mg and 1mg research vials, both priced and ready to order. IGF-1 LR3 is an 83 amino acid analogue of insulin-like growth factor 1 with an arginine at position 3 and a 13 amino acid extension at its start, changes that sharply reduce capture by IGF binding proteins while keeping activity at the IGF-1 receptor. That makes it far more active per microgram in culture than native IGF-1, and it is widely used in cell culture and receptor signalling work. Each vial holds lyophilised protein, sealed and labelled with compound, amount, lot number and storage temperature, and the certificate of analysis for its lot is available on request. Add bacteriostatic water or dilute acetic acid and the order is dispatched from Australian stock to any Australian address. IGF-1 LR3 is sold to adults 18 and over for in-vitro research only, not for human or veterinary use.

1
Frequently bought together
For in-vitro laboratory research only. Not for human or veterinary use. Purchasers must be 18 or over.
CompoundIGF-1 LR3
Amount0.1 mg
FormLyophilised powder
CategoryGrowth hormone research
Storage-20 °C, protect from light
TestingHPLC purity 98% or higher and mass spectrometry identity, every batch
Certificate of analysisAvailable for every lot, matched to the lot number on the label
Peptide calculator

IGF-1 LR3 0.1mg vial

Enter the diluent volume added to this vial to see the solution concentration. Laboratory calculation only, not dosing guidance.

Vial content
0.1 mg
mg per mL0.05
mcg per mL50

Buy IGF-1 LR3 Australia: 0.1mg and 1mg Vials

Macropus Peptides stocks this IGF-1 analogue in two priced fills, a 0.1mg vial (100 micrograms) and a 1mg vial, much smaller than most of our peptides because it is active at very low concentrations. It is a recombinant, long-acting form of insulin-like growth factor 1, supplied as lyophilised research-grade protein for cell culture and receptor work. Every lot carries a matching certificate of analysis, and both fills share one specification.

IGF-1 LR3 Australia: what the peptide is

Insulin-like growth factor 1 (IGF-1) is a 70 amino acid protein, held in shape by three disulfide bridges, whose sequence was published in the Journal of Biological Chemistry in 1978. It is the main hormone through which growth hormone acts on tissues, and it shares close structural kinship with proinsulin. The LR3 analogue is a longer version of 83 amino acids: the glutamic acid at position 3 is replaced with arginine, the R3 in the name, and a 13 amino acid extension is added to the front, the L for long. The finished protein weighs about 9,100 daltons, against roughly 7,650 for native IGF-1. Unlike the short synthetic peptides in our range, it is produced recombinantly in bacteria and then refolded so the three disulfide bridges form correctly. It is a laboratory reagent and has never been a medicine.

How IGF-1 LR3 works in research

Cells in culture release IGF binding proteins, a family of six, that grab native IGF-1 and keep much of it away from its receptor. The two changes in the analogue greatly reduce that binding while leaving it able to activate the IGF-1 receptor, a tyrosine kinase that signals through the PI3K and Akt pathway and the MAPK pathway. More of each microgram therefore reaches the receptor and stays active for longer. Researchers use it to study IGF-1 receptor signalling, cell growth and survival in culture, and muscle and other cell models.

It is also a working ingredient in bioprocessing. Serum-free media for mammalian production cells, such as Chinese hamster ovary lines, often include it in place of insulin or serum-derived growth factors, because binding proteins secreted by the cells do not blunt it. Compared with upstream peptides such as CJC-1295 no DAC and Ipamorelin, which act on the pituitary, it works at the very end of the growth hormone axis, directly on the target cell.

IGF-1 LR3 research: what the studies show

The sequence of native IGF-1 was set out in 1978 in the Journal of Biological Chemistry. A 1989 paper in the Biochemical Journal showed that IGF binding proteins blocked the actions of IGF-1 but not of a truncated form lacking its first three amino acids, pointing to the start of the chain as the key to binding protein capture. The design behind the analogue was reported in 1992 in the Journal of Molecular Endocrinology, which compared fusion analogues to separate binding protein affinity from receptor binding. A 1995 study in the Journal of Endocrinology examined organ growth and circulating IGF and binding protein levels in guinea pigs given the analogue. Together they trace a straight line from sequence, to the binding protein problem, to an engineered answer. Summaries are in our LR3 analogue research studies library.

IGF-1 LR3 vial specifications

SpecificationDetail
CompoundIGF-1 LR3
Amount0.1 mg
FormLyophilised powder
CategoryGrowth hormone research
Storage-20 °C, protect from light

The analogue is supplied as a small lyophilised pellet in a stoppered, crimped vial; with a milligram or less of protein inside, and only 100 micrograms in the smaller fill, the pellet can be hard to see against the glass. The label shows the compound, amount, lot and storage temperature. Its certificate of analysis follows by email once you give us that lot. Keep the sealed vial at -20 °C and protect it from light until use.

IGF-1 LR3 price in Australia and cost per microgram

StrengthPricePrice per mg
IGF-1 LR3 0.1mg$48.99$489.90 per mg
IGF-1 LR3 1mg$139.99$139.99 per mg

Both vials carry fixed Australian dollar prices. The 1mg vial holds ten times the protein of the 0.1mg vial yet costs less than three of them, so it is the clear value per microgram. Because culture work measures this analogue in micrograms and nanograms, it goes a long way: 1,000 micrograms is about 110 nanomoles, enough for many aliquots of working stock from a single lot.

IGF-1 LR3 1mg: the stocked research vial

Most orders are for this vial, which covers extended culture work or a full signalling study on one lot. Taken up in 1 mL it forms a 1 mg per mL stock (1,000 micrograms per millilitre); in 2 mL, a 500 micrograms per millilitre stock. Stocks at this strength are then diluted into media or assay buffer, and a 1 in 1,000 dilution of the 1 mg per mL stock gives 1 microgram per millilitre. Splitting the stock into single-use aliquots straight after mixing protects the remainder from repeated temperature changes.

IGF-1 LR3 0.1mg: a 100 microgram vial for single experiments

The 0.1mg vial suits a one-off experiment, a short test in a new cell line or a check of a supplier change in a validated medium. In 1 mL it gives 100 micrograms per millilitre, and in 0.5 mL it gives 200. Because the pellet is so small, add the liquid slowly and allow it to dissolve completely before drawing any out.

Best place to buy IGF-1 LR3 in Australia

  • Sold online at macropuspeptides.com in 0.1mg and 1mg, priced from $48.99
  • Every batch HPLC tested to 98% or higher purity, with identity confirmed by mass spectrometry
  • A certificate of analysis for every lot, matched to the lot number printed on the label
  • Same-day dispatch from Australian stock for orders paid before 2pm AEST on a business day
  • Tracked delivery Australia wide: standard in 2 to 5 working days, express in 1 to 2 working days
  • Payment by PayID or bank transfer, with your order ID as the reference

How to buy IGF-1 LR3 online

  • Put the 0.1mg or 1mg vial in the cart
  • Choose the number of vials
  • Add a diluent: bacteriostatic water or dilute acetic acid
  • Complete payment after the adult and research-use declarations
  • Record the lot for certificate requests

IGF-1 LR3 calculator: how much bac water or acetic acid for 1mg and 0.1mg

Because the fills are small, work in micrograms. The 1mg vial holds 1,000 micrograms: in 1 mL that is 1,000 micrograms per millilitre, in 2 mL it is 500, and in 5 mL it is 200. The 0.1mg vial holds 100 micrograms: 1 mL gives 100 per millilitre and half a millilitre gives 200. Many laboratories dissolve IGF analogues in a dilute acid such as our acetic acid solution before diluting further in buffer, since the protein stays in solution well at low pH; bacteriostatic water is the alternative. Whichever diluent you pick, note it on the label so later dilutions start from the same basis.

Is IGF-1 LR3 available in Australia

It is available for laboratory research only, which is how we sell it. With neither an ARTG entry nor TGA approval, the analogue cannot lawfully be sold for people or animals. Insulin-like growth factors are dealt with in the TGA's Poisons Standard, and its latest version determines what your organisation may hold.

IGF-1 LR3 for sale Australia wide: local dispatch to every state

From Australian stock we send it to cell culture, bioprocess and signalling laboratories in Brisbane, Hobart, Canberra, Adelaide, Perth, Melbourne, Darwin, Sydney and regional campuses, with no import delay. For work further up the growth hormone axis, the growth hormone research range includes the pituitary-acting peptides, and diluents sit in lab supplies and kits.

References

  1. The amino acid sequence of human insulin-like growth factor I and its structural homology with proinsulin. Journal of Biological Chemistry. 1978.
  2. Insulin-like growth factor (IGF)-binding proteins inhibit the biological activities of IGF-1 and IGF-2 but not des-(1-3)-IGF-1. Biochemical Journal. 1989.
  3. Novel recombinant fusion protein analogues of insulin-like growth factor (IGF)-I indicate the relative importance of IGF-binding protein and receptor binding for enhanced biological potency. Journal of Molecular Endocrinology. 1992.
  4. Long R3 insulin-like growth factor-I (IGF-I) infusion stimulates organ growth but reduces plasma IGF-I, IGF-II and IGF binding protein concentrations in the guinea pig. Journal of Endocrinology. 1995.

Scientific content compiled from the peer-reviewed literature above by the Macropus Peptides technical team. Information is provided for research reference only.

Questions about IGF-1 LR3

Chat on WhatsApp
IGF-1 LR3 0.1mg$48.99